Ziqi Jia

809 total citations
36 papers, 230 citations indexed

About

Ziqi Jia is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ziqi Jia has authored 36 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ziqi Jia's work include Lung Cancer Treatments and Mutations (7 papers), Cancer Cells and Metastasis (5 papers) and BRCA gene mutations in cancer (4 papers). Ziqi Jia is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer Cells and Metastasis (5 papers) and BRCA gene mutations in cancer (4 papers). Ziqi Jia collaborates with scholars based in China, United States and Italy. Ziqi Jia's co-authors include Yanyu Wang, Naixin Liang, Yijun Wu, Yang Song, Jiaqi Liu, Shanqing Li, Zhongxing Bing, Hanfeng Ding, Xiang Wang and Jialei Hu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Organic Chemistry.

In The Last Decade

Ziqi Jia

31 papers receiving 228 citations

Peers

Ziqi Jia
Lanqing Cao China
Ghazal Haddad Canada
Jiang Xu China
Mary L. Guye United States
Liwen Guo China
Ellen C. de Heer Netherlands
Marta Vallee Cobham United States
Ruinian Zheng China
Hongchao Tang China
Shiming He China
Lanqing Cao China
Ziqi Jia
Citations per year, relative to Ziqi Jia Ziqi Jia (= 1×) peers Lanqing Cao

Countries citing papers authored by Ziqi Jia

Since Specialization
Citations

This map shows the geographic impact of Ziqi Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziqi Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziqi Jia more than expected).

Fields of papers citing papers by Ziqi Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziqi Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziqi Jia. The network helps show where Ziqi Jia may publish in the future.

Co-authorship network of co-authors of Ziqi Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Ziqi Jia. A scholar is included among the top collaborators of Ziqi Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziqi Jia. Ziqi Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tao, Yuwei, Tian Chen, Shaolong Qi, et al.. (2025). Targeting both death and paracaspase domains of MALT1 with antisense oligonucleotides overcomes resistance to immune-checkpoint inhibitors. Nature Cancer. 6(4). 702–717. 1 indexed citations
3.
Chen, Weiyue, Mao-Sheng Chen, Xiaotao Han, et al.. (2025). Genome-Wide Identification and Expression Analysis of the Response Regulator (RR) Gene Family in Sacha Inchi. Journal of Plant Growth Regulation. 44(8). 4425–4441. 1 indexed citations
4.
Jia, Ziqi, et al.. (2025). Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance. Journal of Hematology & Oncology. 18(1). 32–32. 16 indexed citations
5.
Jia, Ziqi, Heng Cao, Jiayi Li, et al.. (2025). Advanced strategy for cancer detection based on volatile organic compounds in breath. Journal of Nanobiotechnology. 23(1). 468–468. 2 indexed citations
6.
7.
Li, Bowen, Ziqi Jia, Zhicheng Huang, et al.. (2023). Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report. Translational Lung Cancer Research. 12(11). 2322–2329. 2 indexed citations
8.
Jia, Ziqi, Jiaqi Liu, Gang Liu, et al.. (2023). Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population. Gene. 884. 147676–147676. 1 indexed citations
9.
Jia, Ziqi, et al.. (2023). Biomarkers and experimental models for cancer immunology investigation. SHILAP Revista de lepidopterología. 4(6). e437–e437. 14 indexed citations
10.
Liu, Ying, Li Zhang, Minghui Zhang, et al.. (2023). 336P Dual-mode near-infrared multispectral imaging system equipped with deep learning models improves the identification of cancer foci in breast cancer specimens. Annals of Oncology. 34. S317–S317. 2 indexed citations
11.
Jia, Ziqi, et al.. (2022). A Bayesian Network Meta-Analysis of Complications Related to Breast Reconstruction Using Different Skin Flaps After Breast Cancer Surgery. Aesthetic Plastic Surgery. 46(4). 1525–1541. 1 indexed citations
12.
13.
Yang, Huaxia, Yadong Wang, Ziqi Jia, et al.. (2021). Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer. Frontiers in Oncology. 11. 537735–537735. 9 indexed citations
14.
Zhang, Menglu, Jiaqi Liu, Gang Liu, et al.. (2021). Anti-vascular endothelial growth factor therapy in breast cancer: Molecular pathway, potential targets, and current treatment strategies. Cancer Letters. 520. 422–433. 24 indexed citations
15.
Jia, Ziqi, Jiaxin Li, Yuelun Zhang, et al.. (2021). Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis. Cancer Cell International. 21(1). 512–512. 9 indexed citations
16.
Song, Yang, Ziqi Jia, Yadong Wang, et al.. (2020). Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q. Journal of Thoracic Disease. 12(5). 2771–2780. 5 indexed citations
17.
Liang, Naixin, Lei Liu, Ping Li, et al.. (2020). Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles. Journal of Thoracic Disease. 12(8). 4262–4273. 25 indexed citations
18.
Wang, Yadong, Xiaoying Yang, Xu Tian, et al.. (2020). Neoadjuvant immunotherapy plus chemotherapy achieved pathologic complete response in stage IIIB lung adenocarcinoma harbored EGFR G779F: a case report. Annals of Palliative Medicine. 9(6). 4339–4345. 3 indexed citations
19.
20.
Wang, Yanyu, et al.. (2019). Expression and prognostic analyses of ITGA11 , ITGB4 and ITGB8 in human non-small cell lung cancer. PeerJ. 7. e8299–e8299. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lanqing Cao Breakdown of academic impact, for papers by Ghazal Haddad Breakdown of academic impact, for papers by Jiang Xu Breakdown of academic impact, for papers by Mary L. Guye Breakdown of academic impact, for papers by Liwen Guo Breakdown of academic impact, for papers by Ellen C. de Heer Breakdown of academic impact, for papers by Marta Vallee Cobham Breakdown of academic impact, for papers by Ruinian Zheng Breakdown of academic impact, for papers by Hongchao Tang Breakdown of academic impact, for papers by Shiming He
Rankless by CCL
2026